SouqDataSouqData
CompaniesExchangesDirectorsScreenerAnnouncementsInsightsPortfolioCopilotPricing
SouqData

SouqData

GCC corporate governance intelligence platform — UAE, Jordan, Kuwait, Qatar, Oman, Bahrain, Saudi Arabia

Platform

  • Companies
  • Exchanges
  • Directors
  • Screener
  • Announcements

Explore

  • Exchanges
  • Directors
  • Auditors
  • Board Intelligence
  • Governance
  • Dividends
  • Screener
  • Countries

Company

  • About
  • Contact
  • FAQ
  • Developers
  • Pricing

Legal & Data

  • Terms of Use
  • Privacy Policy
  • Disclaimer
  • Data Sources
  • Data Quality
  • Cookie Policy
  • Acceptable Use
  • Refund Policy
  • Data Retention

SouqData is not licensed, regulated, or supervised by any GCC securities regulator (SCA, DFSA, CMA, QFMA, CBB, or JSC). All content is for general information and educational purposes only and does not constitute financial advice, investment recommendations, or solicitation to buy, sell, or hold any security.

© 2026 Pangaea Capital. Sources · Disclaimer

  1. Home
  2. /Companies
  3. /HITS — Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC logo

Hikma Pharmaceuticals PLC (HITS)

ASE

Hikma Pharmaceuticals PLC

الحكمة للصناعات الدوائية

Health CareJordanJOD
Deep ResearchCompareClaim this company

What Changed

Full IR Briefing →
0
Board Size
0
Announcements (30d)

Company Overview

Ticker: HITS
Exchange: ASE
Sector: Health Care
Industry: -
Market Cap: -
Currency: JOD
FY End: December
Accounting Standard: -
Employees: -
Website: hikma.com

Leadership Team

DG
Daryl G. Baker

Chief Financial Officer

SD
Said Darwazah

Executive Chairman · Since May 1, 2014

KN
Khalid Nabilsi

Chief Financial Officer · Since Jan 1, 2011

HA
Hussein Arkhagha

Chief People Officer · Since Sep 1, 2023

RM
Riad Mishlawi

Chief Executive Officer · Since Sep 1, 2023

BL
Bill Larkins

President of Injectables · Since Sep 1, 2023

SR
Susan Ringdal

Executive Vice President, Strategic Planning and Global Affairs · Since Jan 1, 2012

MD
Mazen Darwazah

Executive Vice Chairman, President of MENA · Since Sep 8, 2005

BK
Bassam Kanaan

Executive Vice President, Corporate Development and M&A · Since Jan 1, 2014

JH
Julie Hill

Senior Vice President, Corporate Quality Compliance/Health and Safety · Since Feb 1, 2024

HF
Hafrun Fridriksdottir

President of Generics · Since Apr 1, 2024

Recent Announcements

No announcements yet.

Data Sources

Financials (1 yrs)Annual Report
Directors (10)Annual ReportAnnual Report

See Data Freshness Monitor for platform-wide data quality.

Price Chart

No price data available

Key Metrics

P/E Ratio-
P/B Ratio-
EV/EBITDA-
Dividend Yield-
ROE-
ROA-
Net Margin-
Debt/Equity-
Net Debt/EBITDA-
FCF Yield-

Governance Score

A83/100

Strong

8-factor live score

Dividend Safety

F

0/100

Accounting Quality

C

55/100

Caution: M-Score elevated

Spot an error?

SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.

Data sources · Full disclaimer · Data freshness

Frequently Asked Questions about Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC vs sector peers

Health Care · unknown-cap · 5 peers shown
CompanyMarket cap (USD)Dividend yieldGovernanceShariah
Hikma Pharmaceuticals PLC (HITS)——42(D)—
Dar Al Dawa Development and Investment (DARAT · ASE)$14M———
Middle East Pharmaceutical & Chemical Industries (MPHA · ASE)————
Arab Center for Pharmaceutical & Chemical Industries (APHC · ASE)————
International Holding Company PJSC (IHC · ADX)$232.9B—42(D)—
Dr. Sulaiman Al-Habib Medical Services Group Co. (4013 · TDWL)$6.3B—42(D)—

Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.

Pro Plan

Unlock the full SouqData platform

Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.

Full ScreenerAI CopilotDeep Research
View PlansStart free — no card required